Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
46 / 100
AltIndex AI Score
Hold
AI Score · 12-mo trend
+2 pts over 3 months33% of GNPX’s tracked signals bullish
FundamentalsBullish
TechnicalsBearish
Alternative dataNeutral
SentimentBullish
Price$2.64
Year Range$2.56 – $58.52
Market Cap$2.2M
PE Ratio0.08
IndustryBiotechnology

What Is Genprex’s AI Stock Analysis?

Genprex’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Genprex’s momentum in near-real time.

Genprex (GNPX) has an AltIndex AI Score of 46/100, currently a Hold signal. The AI Score distills Genprex's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.

Genprex’s Full AI Analysis

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. The company's lead product candidate, Ongogene, is an immunogene therapy for non-small cell lung cancer (NSCLC). By leveraging its proprietary platform technologies, Genprex aims to develop safe and effective gene therapies to treat a range of diseases.

Fundamental Analysis

In the last quarter, Genprex reported a net income of $4.4 million. This represents a quarter-over-quarter increase of 0.33%, which is a positive sign of growth. When compared to the same quarter last year, net income has increased by 4.87%, signaling positive year-over-year growth.

Premium

Keep reading AltIndex’s full AI analysis of Genprex — the fundamental, technical and alternative-data breakdown and the recommendation.

Sign up to read the full analysis

What’s Driving GNPX’s AI Score?

Fundamentals

Net income for the last quarter was $-4.4M. This is an increase of -0.33% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of -4.87%, suggesting positive year-over-year growth. Ebitda for the last quarter was $-4.4M. This is an increase of -0.33% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of -4.84%, suggesting positive year-over-year growth. The current P/E ratio is 0.08. This may be considered low, potentially indicating undervaluation and a bullish outlook.

See Genprex’s earnings and insider transactions.

Technicals

Today's stock price is $2.61. This represents a decrease of 25.43% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 99.03%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $2.70, which is lower than the previous SMA10 of $2.77. This suggests a potential downward trend in price movement. The RSI is 49, indicating a neutral condition.

See the full technical analysis and price prediction.

Alternative data

The business outlook among employees at Genprex is low (an estimate of only 0% of employees have a positive outlook), a concerning sign. Genprex has an estimate of 2,000 visitors to their webpage. The number of visitors is down by -67% in the last couple of months, a worrisome trend as this can indicate a loss in customers.

Explore Genprex’s job postings, web traffic and app downloads.

Sentiment & social

The sentiment for the stock on various stock forums is very high, a positive sign.

Track Genprex’s market sentiment.

Frequently Asked Questions: Genprex AI Stock Analysis

Genprex's AltIndex AI Score is 46/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.

AltIndex's AI Score model rates Genprex a Hold (46/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.

The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.

AltIndex generates a complete written AI analysis of Genprex — company overview, fundamentals, technicals and alternative data, with a recommendation. See the GNPX AI Score or sign up to read the full thesis.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.